Marc Arginteanu

47 posts

Marc Arginteanu banner
Marc Arginteanu

Marc Arginteanu

@MarcSArginteanu

Neurosurgeon and Author. Check out my books https://t.co/ih3SJ1Sj6w

Katılım Mart 2026
36 Takip Edilen6 Takipçiler
Marc Arginteanu
Marc Arginteanu@MarcSArginteanu·
Social Media and the Teen Mental Health CrisisIn a major 2019 UCL study analyzing data from nearly 11,000 British 14-year-olds (Millennium Cohort Study), researchers found a clear, dose-dependent link between social media use and depressive symptoms. The more time spent on social media, the higher the likelihood of clinically significant depression. This held for both sexes, but the impact was markedly stronger for girls. Teenage girls using social media more than five hours a day were three times as likely to be depressed compared to light or non-users. Boys in the heavy-use category were twice as likely to experience mental health issues. The researchers pointed to cyber-bullying, sleep disruption, and body-image pressures as key drivers.Questions worth asking: Are social media companies complicit? Are they doing enough (or anything meaningful) to combat this epidemic? Are parents doing their jobs? This data is from 2019—before the full explosion of TikTok and even heavier smartphone penetration. The trends have not improved.What do you think? Drop your thoughts below.
Marc Arginteanu tweet media
English
0
2
4
57
Marc Arginteanu
Marc Arginteanu@MarcSArginteanu·
Psilocybin can rewire your brain after just one dose.A 2024 Nature study used fMRI scans on volunteers before and after taking the active compound in magic mushrooms. The results were striking: it massively disrupted functional connections across the brain, especially in the Default Mode Network (DMN)—the system responsible for daydreaming, self-reflection, memory, and planning. The DMN nodes (medial prefrontal cortex, posterior cingulate, parietal lobes, and hippocampus) temporarily desynchronized, which may explain the ego dissolution and altered perception people often report. These changes lasted about three weeks before mostly returning to baseline by 6–12 months later. Researchers are exploring psilocybin for depression, PTSD, and other conditions—backed by serious investment from figures like Peter Thiel via companies such as ATAI Life Sciences.Fascinating window into how a single psychedelic experience can temporarily reboot brain wiring.
Marc Arginteanu tweet media
English
2
0
4
42
Marc Arginteanu
Marc Arginteanu@MarcSArginteanu·
Omega-3: The Brain Shield Against Air Pollution Your brain is taking a daily hit from something you can’t even see: PM2.5 air pollution. These tiny particles are 30x smaller than a human hair and can cross the blood-brain barrier, triggering inflammation and hippocampal shrinkage. But there is a powerful way to fight back. As a neurosurgeon, I’m breaking down the latest 2024 and 2025 data showing how Omega-3 fatty acids act as a "biological shield," preserving brain volume and white matter integrity even in polluted environments. #Omega3 #BrainHealth #Neuroscience #AirPollution #Neuroprotection #DementiaPrevention #Neurosurgeon #HealthyAging #TheMindUnlocked #BrainVolume ! #TikTok tiktok.com/t/ZTkCjMjBK/
English
0
1
1
72
Marc Arginteanu
Marc Arginteanu@MarcSArginteanu·
AI Digital Twin Brains Description: We are moving from "one-size-fits-all" medicine to a world where your surgeon can test a procedure on a digital version of your brain before you ever enter the OR. As a neurosurgeon, I am fascinated by the shift from reactive treatment to precise prediction. In this video, we explore the rise of AI Digital Twins in neuroscience. We’ll look at a groundbreaking Stanford study that demonstrates how digital biology is creating personalized "avatars" of the human brain to predict disease progression and optimize individual care. This isn't science fiction—it’s the new frontier of precision medicine. Inside this video: 0:00 - The Shift to Precise Prediction 0:45 - What is a Brain "Digital Twin"? 1:20 - The Stanford Study: Breaking Down the Data 2:00 - From Reactive to Proactive Neurocare 2:45 - Future Implications for Brain Health Featured Research: Stanford University: Digital Twins in Personalized Medicine & Biology Follow for more on the mind-tech frontier: Substack: @marcarginteanu" target="_blank" rel="nofollow noopener">substack.com/@marcarginteanu Medical Disclaimer: This video is for educational and informational purposes only and does not constitute medical advice or a provider-patient relationship. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. #DigitalTwin #BrainAI #Neuroscience #AIDigitalBiology #Neurosurgeon #PrecisionMedicine #TheMindUnlocked #StanfordScience #HealthTech
English
0
2
1
60
Marc Arginteanu
Marc Arginteanu@MarcSArginteanu·
Ibogaine: The Wild Card of Psychedelics The Fear Ibogaine is the "black sheep" of the psychedelic family. It’s powerful, it’s strange, and it has a dangerous edge. The biggest red flag in the medical literature is what it does to the heart. Specifically, it messes with the electrical timing of your heartbeat. This can trigger a chaotic, potentially fatal heart rhythm—even in people who think they’re perfectly healthy. What’s more, it can appear hours to days after ingestion. A 2026 review in the journal Addiction makes it clear: while this drug can kill cravings, its toxicity to the heart can kill you too. We’ve seen dozens of deaths over the years (and case reports continue to pile up) usually because someone wasn't screened properly or wasn't being monitored by a doctor. This isn't just "drug war" talk; it’s the cold, hard science you see in peer-reviewed journals. It’s exactly why ibogaine is still strictly illegal in the United States (Schedule I) and why you should never, ever try it in a basement or a hotel room. The Hope Now, here’s the flip side—and it’s some of the most incredible data I’ve seen in my career. In the Magnesium–Ibogaine: Stanford Traumatic Injury to the CNS (MISTIC) protocol, researchers recently took 30 Special Ops veterans—men who had survived repeated blasts and were struggling with severe brain injuries and PTSD—and gave them a single, medically supervised dose of ibogaine combined with intravenous magnesium to protect their hearts. The results, published in Nature Medicine, were staggering. One month later, their PTSD symptoms dropped by 88% and depression by 87%. These guys went from being severely disabled by their trauma to functioning normally. In a follow-up study, veterans reported vivid life-review replays of trauma, mystical feelings of connectedness, surges of forgiveness and purpose, and even felt their brains actually starting to heal. These narrative themes lined up tightly with the objective symptom relief and neurophysiological shifts (increased theta rhythms, reduced cortical complexity). It’s not just “feeling better”—it’s rapid, embodied healing that conventional treatments rarely touch. Ibogaine’s cardiac toxicity has spurred research into safer synthetic analogs like TBG and 18-MC, which aim to replicate therapeutic effects without the danger. These analogues have the Texas wind at their sails. The Lone Star State is investing tens of millions in independent, rigorously monitored trials. The Bottom Line The truth is, ibogaine is a high-risk, high-reward outlier. The heart risks are non-negotiable, which is why scientists are currently trying to engineer "safer" versions of the molecule. The early signal is strong enough that dismissing it outright would be a mistake. The Stanford data offers a lifeline to veterans and others with brain injuries that we simply cannot ignore. As someone who’s tracked this molecule’s strange journey from African root bark to modern clinic, I believe ibogaine’s weirdness is exactly what makes it worth careful, serious study. It doesn’t fit the classic psychedelic mold, and that may be its greatest strength—if we handle the scary part responsibly, the hope could change lives.
Marc Arginteanu tweet media
English
0
0
0
48
Marc Arginteanu
Marc Arginteanu@MarcSArginteanu·
Vagus Nerve Stimulation Without the Knife: Hope or Hype? I’ve spilled plenty of ink on the "hockey puck" in the chest—implantable VNS. It’s a full-on surgical procedure where electronic leads wrap your vagus nerve. But, can we get the "magic" without the knife? Non-invasive VNS (nVNS or taVNS) is currently the darling of the wellness crowd (touted as a miracle for everything from anxiety to inflammation), but let's separate the signal from the noise. linkedin.com/pulse/vagus-ne…
Marc Arginteanu tweet media
English
0
0
0
18
Marc Arginteanu retweetledi
Marc Arginteanu, MD
Marc Arginteanu, MD@ArginteanuMarc·
long-term exposure to air pollution was tied to shrinkage in the hippocampus — the part of your brain you really need for memory — plus atrophy in the white matter that helps everything in your head communicate properly.
Marc Arginteanu@MarcSArginteanu

Omega 3: The Brain’s Shield Against Pollution Air pollution is quietly poisoning your brain The science on this keeps getting clearer every year. Let me explain one of the biggest culprits: PM2.5. These are tiny particles in the air — fine particulate matter less than 2.5 micrometers across. To give you a sense of scale, that's about 30 times smaller than the width of a human hair. They're so small you can't see them, but they come from car exhaust, industrial emissions, wildfires, and even some household sources. Because of their tiny size, they don't just irritate your lungs — they can slip deep into your bloodstream and cross into the brain, triggering inflammation and oxidative stress that accelerate damage over time. Back in 2020, researchers tracked more than 1,300 older adults and saw something worrying on their MRI scans: long-term exposure to this PM2.5 was tied to shrinkage in the hippocampus — the part of your brain you really need for memory — plus atrophy in the white matter that helps everything in your head communicate properly. The more of these invisible particles people had breathed over the years, the worse the deterioration looked. But there was a bright spot in that same study. Folks who had higher levels of omega-3 fatty acids in their blood — especially from eating non-fried fish like salmon or sardines — showed bigger hippocampal and white matter volumes. Those omega-3s actually seemed to blunt some of the damage from the pollution. And it’s not just that one paper. More recent work in 2025 has piled on the evidence. One study found that even relatively low levels of PM2.5 were linked to faster overall brain shrinkage and more white matter damage over just a few years of follow-up. Another, looking at people from the British Birth Cohort, showed that higher exposure to traffic pollutants like NOx and NO2 in midlife was connected to smaller hippocampal volume and signs of brain tissue loss by the time they hit their late 60s and early 70s. The 2024 Lancet Commission on dementia prevention now lists air pollution — driven heavily by these fine particles — as one of the 14 modifiable risk factors we can actually do something about. It drives inflammation and oxidative stress that speed up brain aging in ways we used to think were inevitable. So what can you do? Start by paying attention to your local air quality — apps make it easy these days. Try to avoid the worst traffic times when you’re outside, and consider a good HEPA filter for your home or office to cut down on the particles you breathe indoors. On the nutrition side, getting more omega-3s through a couple servings of non-fried fatty fish each week is a smart move (or talk to your doctor about a quality supplement if fish isn’t your thing). Layer on the usual brain-health basics too: stay active, keep your blood pressure in check, and keep your mind and social life engaged. Look, your brain is taking a daily hit from something you can’t even see. But a lot of this risk is modifiable. Small, consistent choices really can add up and help protect what matters most upstairs.

English
0
1
1
76
Marc Arginteanu
Marc Arginteanu@MarcSArginteanu·
Omega 3: The Brain’s Shield Against Pollution Air pollution is quietly poisoning your brain The science on this keeps getting clearer every year. Let me explain one of the biggest culprits: PM2.5. These are tiny particles in the air — fine particulate matter less than 2.5 micrometers across. To give you a sense of scale, that's about 30 times smaller than the width of a human hair. They're so small you can't see them, but they come from car exhaust, industrial emissions, wildfires, and even some household sources. Because of their tiny size, they don't just irritate your lungs — they can slip deep into your bloodstream and cross into the brain, triggering inflammation and oxidative stress that accelerate damage over time. Back in 2020, researchers tracked more than 1,300 older adults and saw something worrying on their MRI scans: long-term exposure to this PM2.5 was tied to shrinkage in the hippocampus — the part of your brain you really need for memory — plus atrophy in the white matter that helps everything in your head communicate properly. The more of these invisible particles people had breathed over the years, the worse the deterioration looked. But there was a bright spot in that same study. Folks who had higher levels of omega-3 fatty acids in their blood — especially from eating non-fried fish like salmon or sardines — showed bigger hippocampal and white matter volumes. Those omega-3s actually seemed to blunt some of the damage from the pollution. And it’s not just that one paper. More recent work in 2025 has piled on the evidence. One study found that even relatively low levels of PM2.5 were linked to faster overall brain shrinkage and more white matter damage over just a few years of follow-up. Another, looking at people from the British Birth Cohort, showed that higher exposure to traffic pollutants like NOx and NO2 in midlife was connected to smaller hippocampal volume and signs of brain tissue loss by the time they hit their late 60s and early 70s. The 2024 Lancet Commission on dementia prevention now lists air pollution — driven heavily by these fine particles — as one of the 14 modifiable risk factors we can actually do something about. It drives inflammation and oxidative stress that speed up brain aging in ways we used to think were inevitable. So what can you do? Start by paying attention to your local air quality — apps make it easy these days. Try to avoid the worst traffic times when you’re outside, and consider a good HEPA filter for your home or office to cut down on the particles you breathe indoors. On the nutrition side, getting more omega-3s through a couple servings of non-fried fatty fish each week is a smart move (or talk to your doctor about a quality supplement if fish isn’t your thing). Layer on the usual brain-health basics too: stay active, keep your blood pressure in check, and keep your mind and social life engaged. Look, your brain is taking a daily hit from something you can’t even see. But a lot of this risk is modifiable. Small, consistent choices really can add up and help protect what matters most upstairs.
Marc Arginteanu tweet media
English
0
0
1
103
Marc Arginteanu
Marc Arginteanu@MarcSArginteanu·
The Agony and the Ecstasy of MDMA: latest research As someone who’s spent years digging into neuroscience, psychiatry, and the messy realities of substance use, I keep coming back to the same truth about MDMA (street names “Molly” and “Ecstasy”): it’s not inherently good or bad. It’s a tool whose effects hinge entirely on dose, purity, frequency, and context. Street MDMA can quietly erode memory and brain health over time. Yet in tightly controlled clinical settings, the very same molecule—paired with therapy—shows remarkable promise for healing trauma. The latest research sharpens this divide. Below I break it down into two parts: the clear dangers of recreational use and the emerging therapeutic boon for PTSD and related conditions. I’ve pulled directly from peer-reviewed sources. No hype—just the data. Dangers of Recreational Use Recreational MDMA—often taken at higher, repeated doses in uncontrolled settings—carries measurable risks to memory and cognition, especially in still developing brains. Two recent analyses stand out. First, in 2025, Australian scientists embarked on a systematic review and meta-analysis, which examined long-term neurocognitive effects in people who had abstained from MDMA for at least six months. The team analyzed multiple studies and found consistent evidence that both current and former recreational users performed worse on learning and memory tasks than MDMA-naïve controls. Critically, there was no meaningful difference between current and previous users who were abstinent, and longer abstinence did not predict recovery. Evidence for deficits in other domains (executive function, attention) was weaker or inconsistent, but the memory findings held up across the data. The researchers rated the overall evidence quality as low, largely due to observational designs and polydrug confounding—yet the signal on memory is hard to ignore. Second, adolescent brains appear especially vulnerable. A 2025 review by an Italian research team synthesized human and animal data on MDMA exposure during the teenage years. Key takeaways: early use correlates with higher rates of depressive and anxious symptoms, suicidal ideation, and neuropsychological deficits in memory, attention, and executive function. Neuroimaging points to disrupted serotonergic pathways (including reduced serotonin transporter binding) and abnormal hippocampal activity during memory tasks. Because adolescence is a period of heightened neuroplasticity, the authors argue that MDMA’s impact on serotonin and dopamine systems may produce more persistent changes than in adults. Small samples and polydrug use remain limitations, but the pattern is concerning enough to warrant strong prevention messaging for teens. Taken together, these studies reinforce what harm-reduction advocates have long said: street Molly is unpredictable, often adulterated, and repeated recreational use can leave lasting cognitive footprints—especially if started young. Boon for PTSD (and Other Psychiatric) Treatment Flip the script to clinical MDMA-assisted therapy (MDMA-AT)—typically 80–120 mg doses given 2–3 times, weeks apart, within structured psychotherapy—and the picture shifts from risk to potential benefit. In a 2025 study, California based researchers used brain scans to see how a single dose of MDMA affects adults with past trauma. They focused on folks whose "fear center"—the amygdala—was naturally stuck in overdrive. For these patients, MDMA calmed down the amygdala, which acts like a smoke detector for threats, and the subgenual anterior cingulate cortex (sgACC), an area that processes deep-seated emotions. It also helped these two regions communicate better, which made people feel less overwhelmed by scary or negative facial expressions. Essentially, the drug didn’t damage the brain; instead, it seemed to "reset" the circuits responsible for negative emotions, helping the plumbing of the brain handle fear more efficiently. On the purely clinical side, a big 2024 review performed by a multi-national group of researchers looked at nine solid studies with 297 people who had full-blown PTSD. They tested MDMA-assisted therapy against control groups that got either a tiny dose of MDMA or a placebo, plus regular therapy. The people who got the real MDMA therapy saw a really big drop in their PTSD symptoms. More of them responded well to treatment, and more than twice as many actually got rid of their PTSD compared to the control groups. Safety-wise, it looked good—no big jump in side effects, serious problems, or thoughts of suicide. The researchers said it even worked well for people who hadn’t gotten better with other treatments before These findings align with broader mechanistic hypotheses—MDMA may temporarily dampen fear responses, boost empathy and emotional openness, and create a therapeutic window for processing trauma. Importantly, the doses, spacing, and psychotherapy framework used in trials differ dramatically from recreational patterns. Bottom Line MDMA is neither miracle drug nor universal toxin. Recreational Molly, especially in adolescents or with repeated high doses, carries documented risks to memory and brain development. In contrast, regulated MDMA-assisted therapy for PTSD appears safe and efficacious in the latest controlled research, with neuroimaging support for beneficial circuit-level changes. We still need longer-term data, active-control trials, and more diverse populations. But the evidence gap between street use and clinical use has never been clearer. If you or someone you know is struggling with trauma, evidence-based therapies exist today—and MDMA-AT may soon expand those options under medical supervision. For recreational users, testing kits, dose awareness, and harm-reduction resources remain essential. Stay curious, stay safe, and let the data guide the conversation.
Marc Arginteanu tweet media
English
0
1
1
113
Marc Arginteanu
Marc Arginteanu@MarcSArginteanu·
Forge the neural circuit to find your peace. “Peace be upon you,” is a traditional greeting throughout the world. Arabic: As-salamu alaykum. Hebrew: Ma shlomeach. Aramaic (the language Jesus spoke): Shlama 'allāwkhon. Urdu (Pakistan/India): Assalamu alaikum. Wolof (West Africa): A-sala māleykum. These words carry the same wish across cultures and centuries: may peace rest on you, within you, around you. So, how can you manifest this wish in your own life? In a previous post, I discussed developing the neural hardware that decouples your happiness from the tyranny of time. That simple 18-minute breath-sensing drill—sitting still, eyes closed, attending only to the raw feel of inhale and exhale—trains the entorhinal cortex ramp cells, quiets the narrative chatter, and feeds the suprachiasmatic nucleus clean, unfiltered duration data. Over weeks, subjective time perception sharpens dramatically. You stop racing against the clock and start inhabiting the moment. Life stops slipping away; afternoons just... unfold. But here's the next level: mastering that same presence under duress, while physically uncomfortable, will be a big step towards maintaining your inner peace during the physical and mental challenges that beset us throughout the course of our lives. OK, but how? Heat is one brutally honest teacher. So, if you can get 18 right in a steam room—120 degrees, 100% humidity—you can find your peace in any situation. The drill is identical: sit (or lie if you must), eyes closed, feel only the breath—cool in, warm out, belly rising, falling. No forcing, no judging, just sensation. When you think roughly 18 minutes have passed, open your eyes and check the clock (keep it outside the steam if possible—nobody wants melted electronics). Most people crash hard the first few tries. Sweaty guesses swing wildly: “8 minutes?” (real: 4). “25?” (real: 11). The body screams, the mind narrates disaster, anticipation hijacks duration. Yet repeat daily—or as often as tolerable—and the same calibration happens. The entorhinal grid steadies even as skin burns and heart pounds. The “now” stops shrinking under threat and starts expanding. I’ve watched friends go from panic at minute three to nailing 18:00 ±20 seconds amid literal hellish heat. They win! Neural hardware upgrade happens. Battle-tested. Stress, pain, grief, uncertainty—the usual tyrants—lose their grip on their subjective clocks. Peace isn't the absence of storm; it's the eye that remains steady inside it. Try it. Start easy, build tolerance, then take it into the fire (literal or figurative). Once you can sit with the breath for 18 clean minutes while your body begs for escape, very little external chaos can steal your peace again. Peace be upon you—and may you carry it unflinchingly. brain2mind.substack.com/p/master-your-…
Marc Arginteanu tweet media
English
0
0
0
27
Marc Arginteanu
Marc Arginteanu@MarcSArginteanu·
Seed oils and your brain: Sifting through the BS I've seen the hype machine go full throttle on seed oils—canola, soybean, sunflower, corn, the usual suspects. Social media screams they're poison. That may be so regarding your lesser organs (that is, everything besides your brain). But I’ve sorted through the latest brain science and I’m here to refute the hype: Seed oils broil your neurons like bugs under a magnifying glass, driving cerebral inflammation straight to dementia town. Let's cut through the noise, because the science doesn't back the panic. Seed oils have gotten a bad rap The anti-seed-oil crowd loves animal studies where mega-doses of linoleic acid (the main omega-6 in most seed oils) crank up oxidative stress or neuroinflammation in rats on weird diets. Add in concerns about repeated heating in deep-fryers creating nasty compounds like 4-HNE (it even sounds NEfarious), and suddenly every bottle of canola is the villain. Throw in the "industrial seed oils are processed with chemicals" angle, and it's easy to see why people freak out. But here's the thing: most of these fears come from preclinical models or extreme scenarios that don't match how normal humans eat. Typical dietary amounts? Not the same story. The latest science refutes the doom narrative The big bombshell dropped in early 2026 from the UK Biobank—the massive ongoing cohort with hundreds of thousands of people like you and me, who were tracked over years. A prospective study (published in The American Journal of Clinical Nutrition) looked at plasma levels of n-6 polyunsaturated fatty acids and incident dementia risk. Over ~15 years of follow-up, with thousands of dementia cases identified, higher plasma linoleic acid (LA—the primary fatty acid in most common seed oils) was tied to significantly lower dementia risk. You read that right, LOWER. Specifically, people in the highest quintile of LA had an 18% lower risk compared to the lowest quintile, even after adjusting for confounders like age, sex, education, APOE status, lifestyle, and cardiometabolic factors. What makes this even more telling? The researchers distinguished LA from other non-LA omega-6 fats (like arachidonic acid derivatives, often from animal sources or further metabolism). Those non-LA n-6 PUFAs showed the opposite: highest levels linked to a 21% higher dementia risk. This isn't a blanket "omega-6 bad" story—it's nuanced. LA itself (from plant sources like seed oils, nuts, seeds) appears protective, while other omega-6 pathways might not be. As the lead authors noted, this is the largest analysis of its kind, adding real clarity to the debate: linoleic acid tracks with lower dementia risk, not higher. This aligns with a solid 2024 review on LA and alpha-linolenic acid (ALA) in metabolic-related dementia. In folks with metabolic syndrome (insulin resistance, dyslipidemia—the stuff that quietly wrecks brains over time), LA steps up: it attenuates neuroinflammation by dialing down pro-inflammatory pathways, improves lipid profiles (boosting HDL, regulating metabolism), enhances insulin signaling in the brain, supports synaptic plasticity for better learning/memory, and directly counters Alzheimer's hallmarks like synaptic loss and amyloid/tau issues. Inadequate LA intake, not excess, gets linked to worse cognitive outcomes and neuropsychiatric problems like depression. The takeaway? These essential fatty acids from vegetable oils and seeds help tackle both metabolic and neurological threats simultaneously—no evidence of harm at typical intakes; instead, they're positioned as supportive for brain resilience in at-risk groups. Broader consensus backs this up. Reviews and expert takes from 2025 (Johns Hopkins, American Heart Association, American Society for Nutrition, Stanford nutrition researchers) consistently show LA does NOT drive inflammation in humans—the old fear was based on cell/animal data that doesn't hold in people. Blood/tissue LA levels correlate with lower chronic disease risks, including cardiometabolic ones that feed into brain decline. A standout 2025 presentation at NUTRITION 2025 analyzed nearly 1,900 people and found higher LA tied to lower inflammation markers and better cardiometabolic health—directly challenging the "seed oils cause inflammation" claim. On the other hand, there is some there, there Oxidation during repeated heating? Yes, that's a legitimate issue in commercial deep-frying or abused home oil—generating compounds like 4-HNE that animal/in vitro work links to neuronal stress. But in typical use (fresh oils, moderate cooking, with built-in vitamin E as antioxidant), levels stay low, and large human studies don't show brain harm from standard seed oil consumption. Replacing saturated fats (butter, lard) with these PUFAs often improves outcomes. Bottom line from the freshest data: No robust evidence that seed oils harm the brain in humans. Instead, prospective giants like UK Biobank and mechanistic reviews point to LA as neutral at worst, protective at best—especially for dementia risk amid metabolic chaos. The anti-seed-oil echo chamber leans on outdated preclinical fears or ignores this nuance. Science says chill on the panic. Some seed oils benefit the brain As I discussed in a previous post (brain2mind.substack.com/p/seed-oils-th…) some seed oils are more hero than villain. Coconut oil gets a bad rap in some circles as "saturated fat overload," but I see it differently—especially when we're talking brain fuel. Technically from the coconut "seed" (the endosperm), it's loaded with medium-chain triglycerides (MCTs) like lauric, caprylic, and capric acids that metabolize fast into ketones. In Alzheimer's and mild cognitive impairment, the brain struggles with glucose uptake, creating an energy deficit—ketones step in as an alternative fuel source, bypassing those broken pathways. A 2024 systematic review and meta-analysis on coconut oil's bioactive metabolites in AD and dementia highlighted potential benefits: modifying disease pathways via ketones, with some studies showing cognitive improvements in orientation, language, and overall scores compared to controls. Earlier work, like the VCO-AD randomized trial in Sri Lanka, found virgin coconut oil supplementation improved cognition in mild-to-moderate AD patients, particularly in those without the APOE ε4 risk allele. Anecdotal reports and caregiver analyses (hundreds of cases) often note gains in memory, mood, behavior, and daily function with consistent use. As I wrote in my Substack piece on beneficial seed oils, the evidence suggests coconut oils provide practical neuroprotection—think steady ketone supply for a starving brain. Start with a tablespoon or two daily (in coffee, cooking, or straight), build tolerance to avoid GI upset, and pair with a balanced diet. Not a cure, but in the fight against cognitive decline, it's one tool with solid mechanistic and emerging clinical backing—far from the villain it's sometimes painted as. Pomegranate seed oil stands out as one of those "not all seed oils are created equal" gems—far from the villainized canola or soy crowd. Pomegranates might've been the forbidden fruit in Eden, but modern science shows their seed oil is a straight-up blessing for the brain. Packed with punicic acid (a rare conjugated linolenic acid) and potent polyphenols, it delivers serious antioxidant and anti-inflammatory firepower. In a solid 2024 Greek clinical trial, researchers gave older adults with mild cognitive complaints just 5 drops of pomegranate seed oil daily (versus placebo sugar water) for a full year. The results? Significant improvements in thinking function—better memory, sharper problem-solving, and enhanced decision-making—while the placebo group lagged behind. This builds on earlier work showing pomegranate extracts speed neurological recovery post-stroke and fight oxidative damage in dementia models. As a neurosurgeon who's watched brains battle decline, I see this as practical neuroprotection: small dose, big payoff in cognition without the processing baggage of ultra-refined oils. Toss a few drops into smoothies or salads—your neurons will appreciate the upgrade. Bottom line? Ditch the fear-mongering. Seed oils aren't the root of all brain evil—poor overall diet, metabolic mess, and chronic stress are bigger threats. Use them sensibly (fresh, not repeatedly fried), balance with omega-3s, and focus on evidence over echo chambers. Your brain will thank you. Stay sharp out there.
Marc Arginteanu tweet media
English
0
0
0
82